UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice

Human reproduction (Oxford), 2009-06, Vol.24 (6), p.1322-1329

2009

Volltextzugriff (PDF)

In vitro and in vivo activity of AS101 against West Nile virus (WNV)

Virus research, 2012-06, Vol.166 (1-2), p.68-76

2012

Volltextzugriff (PDF)

Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101

British journal of dermatology (1951), 2008-03, Vol.158 (3), p.578-586

2008

Volltextzugriff (PDF)

Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models

The FASEB journal, 2007-06, Vol.21 (8), p.1870-1883

2007

Volltextzugriff (PDF)

Role of Endogenous Cytokines Secretion in Radioprotection Conferred by the Immunomodulator Ammonium Trichloro(dioxyethylene-0-0')tellurate

Blood, 1995-03, Vol.85 (6), p.1555-1561

1995

Volltextzugriff (PDF)

Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention

The Journal of immunology (1950), 2002-07, Vol.169 (1), p.384-392

2002

Volltextzugriff (PDF)

Ammonium trichloro(dioxoethylene-o, o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop

Cancer research (Chicago, Ill.), 2004-03, Vol.64 (5), p.1843-1852

2004

Volltextzugriff (PDF)

A new immunomodulating compound (AS-101) with potential therapeutic application

Nature (London), 1987-11, Vol.330 (6144), p.173-176

1987

Volltextzugriff (PDF)

The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma

The Journal of immunology (1950), 1996-02, Vol.156 (3), p.1101-1109

1996

Volltextzugriff (PDF)

Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice

Experimental hematology, 1995-12, Vol.23 (13), p.1358

1995

Volltextzugriff (PDF)

Radioprotective effects of the immunomodulator AS101

The Journal of immunology (1950), 1990-09, Vol.145 (5), p.1512-1517

1990

Volltextzugriff (PDF)

In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin

Cellular immunology, 1992-08, Vol.143 (1), p.143-153

1992

Volltextzugriff (PDF)

Synergism between AS101 and PMA in lymphokine production

Immunology, 1990, Vol.69 (1), p.110-116

1990

Volltextzugriff (PDF)

The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment

Experimental hematology, 1992-12, Vol.20 (11), p.1302-1308

1992

Volltextzugriff (PDF)

Synergistic anti‐tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with ras‐dependent signal‐transduction pathways

International journal of cancer, 2000-04, Vol.86 (2), p.281-288

2000

Volltextzugriff (PDF)

Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels

The Journal of immunology (1950), 1997-09, Vol.159 (6), p.2658-2667

1997

Volltextzugriff (PDF)

Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101

JNCI : Journal of the National Cancer Institute, 1996-09, Vol.88 (18), p.1276-1284

1996

Volltextzugriff (PDF)

Up-Regulation by Ammonium Trichloro(Dioxoethylene-0,0') Tellurate (AS101) of Fas/Apo-1 Expression on B16 Melanoma Cells: Implications for the Antitumor Effects of AS101

The Journal of immunology (1950), 1998-10, Vol.161 (7), p.3536-3542

1998

Volltextzugriff (PDF)

Mechanism of radioprotection conferred by the immunomodulator AS101

Experimental hematology, 1993-01, Vol.21 (1), p.150

1993

Volltextzugriff (PDF)

The effect of the immunomodulator agent AS101 on interleukin‐2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti‐DNA antibody

Clinical and experimental immunology, 1990-03, Vol.79 (3), p.443-447

1990

Volltextzugriff (PDF)

Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101

Radiation research, 1993-11, Vol.136 (2), p.197

1993

Volltextzugriff (PDF)

Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin

Immunology, 1990-08, Vol.70 (4), p.473-477

1990

Volltextzugriff (PDF)

The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent

International journal of immunopharmacology, 1992-05, Vol.14 (4), p.613-619

1992

Volltextzugriff (PDF)

The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action

Cancer research (Chicago, Ill.), 1993-12, Vol.53 (24), p.5962-5969

1993

Volltextzugriff (PDF)

Protective and restorative role of AS101 in combination with chemotherapy

Cancer research (Chicago, Ill.), 1991-03, Vol.51 (5), p.1499-1503

1991

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(41)
Tagungsberichte
(1)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Animals
(42)
Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Ethylenes - Pharmacology
(29)
Mice, Inbred Balb C
(27)
Male
(24)
Adjuvants, Immunologic - Pharmacology
(20)
Biological And Medical Sciences
(20)
Medical Sciences
(15)
Pharmacology. Drug Treatments
(14)
Female
(12)
Humans
(12)
Immunology
(11)
Biochemistry & Molecular Biology
(8)
Ethylenes - Administration & Dosage
(8)
Cells, Cultured
(7)
Ethylenes - Therapeutic Use
(7)
Immunomodulators
(7)
Spleen - Cytology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice

In vitro and in vivo activity of AS101 against West Nile virus (WNV)

Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101

Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models

Role of Endogenous Cytokines Secretion in Radioprotection Conferred by the Immunomodulator Ammonium Trichloro(dioxyethylene-0-0')tellurate

Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention

Ammonium trichloro(dioxoethylene-o, o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop

A new immunomodulating compound (AS-101) with potential therapeutic application

The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma

Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice

Radioprotective effects of the immunomodulator AS101

In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin

Synergism between AS101 and PMA in lymphokine production

The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment

Synergistic anti‐tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with ras‐dependent signal‐transduction pathways

Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels

Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101

Up-Regulation by Ammonium Trichloro(Dioxoethylene-0,0') Tellurate (AS101) of Fas/Apo-1 Expression on B16 Melanoma Cells: Implications for the Antitumor Effects of AS101

Mechanism of radioprotection conferred by the immunomodulator AS101

The effect of the immunomodulator agent AS101 on interleukin‐2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti‐DNA antibody

Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101

Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin

The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent

The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action

Protective and restorative role of AS101 in combination with chemotherapy

Aktive Filter

Suchergebnisse filtern